Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: A pilot study
Akira Sezai(Nihon University), Atsushi Hirayama(Nihon University), Satoshi Kunimoto(Nihon University), Mitsumasa Hata(Nihon University), Motomi Shiono(Nihon University), Tishiko Nakai(Nihon University), Isamu Yoshitake(Nihon University)
Cited by 75
Related Papers
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
|Circulation Journal|2020|345
Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)
|Circulation Journal|2013|120
Effects of Canagliflozin in Patients with Type 2 Diabetes and Chronic Heart Failure: A Randomized Trial (CANDLE)
|ESC Heart Failure|2020|109
Results of Low-Dose Human Atrial Natriuretic Peptide Infusion in Nondialysis Patients With Chronic Kidney Disease Undergoing Coronary Artery Bypass Grafting
|Journal of the American College of Cardiology|2011|108